secwatch.observer — SEC 8-K summary
======================================

Issuer:     PANACEA LIFE SCIENCES HOLDINGS, INC. (PLSH)
CIK:        0001552189
Form:       8-K
Filed at:   2023-10-02T23:59:59+00:00
Accession:  0001493152-23-034965
Event type: m_and_a
Sentiment:  positive
Materiality: 0.70
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Panacea Life Sciences acquires PUR Life Medical franchise for $1M cash plus up to $1.6M contingent
--------------------------------------------------------------------------------

- Purchase price of $1M cash plus up to $1.6M payable over 4 years based on franchise fee and royalty collection.
- Cash due in two tranches: $180,000 upon receipt of auditable financials and $820,000 on November 10, 2023.
- Founder Dan Olsen (58.5% owner of PUR Life) retains 7% of new subsidiary; Panacea holds 93%.
- Acquisition adds 60+ franchise locations, alternative medicine and pain management services to Panacea's vertical integration.
- Panacea plans to finance the cash portion through debt and equity.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1552189/000149315223034965/0001493152-23-034965-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1552189/000149315223034965/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-034965

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer